NEW

FDA Plans eMDR System Updates

The U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH) plans to update the FDA’s electronic medical device reporting (eMDR) system to reflect updates to the FDA Form 3500A and other system enhancements. The FDA Form 3500A is...

FDA Clears GE Healthcare’s Deep Learning-Based MR Image Reconstruction

GE Healthcare has announced U.S. FDA 510(k) clearance of AIR Recon DL. “This pioneering technology, using a deep learning-based neural network, improves the patient experience through shorter scan times while also increasing diagnostic confidence with better image...

GlobalData: Impact of COVID-19 on diagnostic imaging not as severe compared to other areas

The impact of COVID-19 on diagnostic imaging (DI) procedures will not be as severe compared to other therapy areas, such as aesthetics and dental, since only 38.7% of these procedures are elective and expected to drop due to the COVID-19 pandemic, according to...

FDA Approves Cerianna

PETNET Solutions Inc., a Siemens Healthineers company, and Zionexa USA, a wholly owned subsidiary of Zionexa SAS, have announced that the Food and Drug Administration (FDA) has approved Cerianna (fluoroestradiol F 18) injection for intravenous use. Cerianna...

ClearRead CT Installations Accelerate

With the radiologist’s increasing workload, tools that improve reading efficiency while increasing reading accuracy are imperative. Radiology centers and services are utilizing ClearRead CT as a way to standardize care based on proven reading benefits, ease of use and ease of installation. Leading centers such as, Duke University Medical Center, Saint Luke’s Kansas City, Einstein Medical Center, University of Maryland, and the University of Michigan have deployed ClearRead CT technology along with multiple radiology reading services. As a result, ClearRead CT is now processing data from nearly 50 CT scanners that include all major manufacturer CT devices, while being read on the sites existing picture archiving and communication systems (PACS).

“Riverain’s ClearRead CT has been deployed as a part of our routine chest CT exams, including patients in our lung cancer screening program,” said Dr. Jared Christensen, Division Chief of Cardiothoracic Imaging and Imaging Director of Duke’s Lung Cancer Screening Program. “The ClearRead CT technology has helped us to detect lung nodules that may have otherwise been missed. Based upon our early experience, the workflow is faster and more accurate than existing technologies.”

ClearRead CT is the first advanced visualization product cleared by the FDA for concurrent reading, enabling radiologists to read the original series and the processed CT series simultaneously. ClearRead CT is proven to achieve a 26 percent reduction in reading time and reduce missed nodules by 29 percent.

ClearRead CT processes CT scans from all manufacturers and automatically places the processed series into the existing patient file prior to the exam review. The seamless integration and ability to process cases from varying acquisition devices and protocols allows the ClearRead CT technology to be deployed enterprise wide, establishing a standard of care for the patient population.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *